Skip to content

Prostaglandins Use Before Mirena IUD Insertion in Prev CS Women During Lactational Amenorrhea

Prostaglandins Use Before Mirena IUD Insertion in Prev CS Women During Lactational Amenorrhea

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04646161
Enrollment
400
Registered
2020-11-27
Start date
2020-11-25
Completion date
2022-03-01
Last updated
2021-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

to Study the Estimate Difficulty of Insertion Mirena IUD With Use of Prostaglandins

Brief summary

This is a prospective randomized controlled study to determine the effect of prostaglandin intake before Mirena IUD insertion It was conducted at the Department of Obstetrics & Gynecology, Kasr El-Ainy Teaching Hospital, Faculty of Medicine, Cairo University,

Detailed description

The study aiming to measure the estimate difficulty of insertion of the Mirena IUD by using prostaglandins 2 hours before the procedure and the effect of prostaglandins to make this procedure easy with other side effects and complications as bleeding perforation, nausea, vomiting, failure of insertion and comparing them with a placebo group who didn't receive prostaglandins

Interventions

DRUGMisoprostol

misoprostol 200 mcg will be given sublingual 2 hrs before mirena iud insertion

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* 1- Women in lactational amenoeehea with pregnancy test negative 2- Women who had caesarean section within 6 monthes of IUD insertion 3- No medical disorders

Exclusion criteria

* 1- Women in regular menses 2- Medical disorders 3- Nulligravida or muligravida with NVD 4- Women with history of Previous CS more than one CS 5- Any congenital uterine anomalies, fibroids and adenomysis 6- Chronic pelvic pain 7- Intrauterine adhesions 8- Spasmodic dysmenohrrea 9- Allergy to misoprostol

Design outcomes

Primary

MeasureTime frameDescription
Difficulty of insertion of Mirena IUD by using the Ease of Insertion score graduated as VAS like scaleDuring the interventionBy using the visual analogue score

Secondary

MeasureTime frameDescription
cervical dilataion < 4 mmDuring the interventionneed for cervical dilatation to pass the IUD
Pain at insertion according to VASDuring the interventionBy using the visual analogue score
side effects during IUD insertion: bleeding, vasovagal reaction, cramps, nausea, perforation, vomitingDuring the interventionBleeding by using the soaked bads
Subjective sensation of satisfaction graduated as VAS like scaleDuring the interventionBy using the visual analogue score like system
side effects after 30 days of IUD insertion: spotting, cramps, acute PID and expulsionAfter 30 days of intervention
Duration of insertion(min)During the interventionFrom start of procedure till removing the speculum
side effects after 24 hrs of IUD insertion: nausea, vomiting, cramps and hyperthermiaDuring the first 24 hours

Countries

Egypt

Contacts

Primary Contacthany saad, assisstant prof
hanysaad25280@gmail.com01001817211
Backup Contacthadeer meshaal, assistant prof
dr_hadeer@live.com01001435238

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026